Treatment and Prescribing

The CDC has specific recommendations for people considered to be at risk for serious illness from COVID-19.

• People with certain medical conditions, older adults aged 65 years and older, people in a nursing home or long-term care facility are considered to be at higher risk for severe illness

• Long-standing systemic health and social inequities have put various groups of people at increased risk of getting sick and dying from COVID-19, including many racial and ethnic minority groups and people with disabilities

Treatment

• New: Clinical Trials.Gov – Learn more about clinical studies related to COVID-19

  Massachusetts Department of Public Health guidance on Use of Therapeutics for Treatment of COVID-19

  Massachusetts COVID-19 Therapeutics Locator and COVID-19 Therapeutic Look Up Tool assist providers in locating healthcare facilities and sites who have a supply of monoclonal antibodies or oral antivirals and are accepting referrals for therapy

  Department of Health and Human Services (HHS) COVID-19 Therapeutics Locator - Provides a national map displaying public locations that have received shipments of U.S. Government-procured COVID-19 therapeutics; the locations displayed in the locator have reported stock on hand within the last day, including the monoclonal antibody Treatment Evusheld (Astra Zeneca), as well as the oral antiviral therapies Paxlovid (Pfizer), and molnupiravir (Merck)

  Treatments used for COVID-19 should be prescribed by your healthcare provider; people have been seriously harmed and even died after taking products not approved for COVID-19, even products approved or prescribed for other uses; the CDC has information on Treatments Your Healthcare Provider Might Recommend if You Are Sick

  Clinical Guidance on COVID-19 Therapeutics from the Massachusetts Department of Public Health

  A NIH panel of U.S. physicians, statisticians, and other experts has developed the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines; these guidelines, intended for healthcare providers, are based on published and preliminary data and the clinical expertise of the panelists

  The CDC Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19) web page provides clinical care guidance for healthcare professionals about COVID-19

Prescribing

• The MMS has put together Frequently Asked Questions: Prescribing During Remote/Telemedicine Practice that answers key questions regarding remote prescribing.